CREXONT ER

DRUG2 trials

Sponsors

Impax Laboratories, LLC, The Cleveland Clinic

Conditions

Parkinson Disease

Phase 4

A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's Disease

RecruitingNCT06765668

Impax Laboratories, LLCParkinson Disease

Start: 2025-02-12End: 2026-08-06Target: 220Updated: 2025-08-24

BOOST-PD A Naturalistic Study on IPX-203 for Parkinson's Disease

RecruitingNCT07138560

The Cleveland ClinicParkinson Disease

Start: 2025-07-24End: 2027-05-15Target: 22Updated: 2026-06-23